Chemo-Mobilization of Autologous Hematopoietic Progenitor Cells (HPCs) with a Single Dose of Pegfilgrastim and Supplemental Filgrastim in Patients with Multiple Myeloma and Lymphoma: A Practical Schema

被引：0
|
作者：
McCallen, Margaret R. [1 ]
Torloni, A. Sergio [1 ]
Jackson, Marin L. [1 ]
Ulrickson, Matthew L. [1 ]
Peterson, Mary E. [1 ]
Adams, Christine E. [1 ]
Escalante, Tracey D. [1 ]
Mitchell, September [1 ]
Akpek, Goerguen [1 ]
机构：
[1] Banner MD Anderson Canc Ctr, Gilbert, AZ USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2014.11.220
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
185
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [41] A Novel Hematopoietic Progenitor Cell (HPC) Mobilization Regimen, Utilizing Bortezomib and Filgrastim (G-CSF), for Patients Undergoing Autologous HPC Transplant (AHPCT) for Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)
    Abhyankar, Sunil
    DeJarnette, Shaun
    Bunch, Jennifer
    Merkel, Dean
    Ganguly, Siddhartha
    Aljitawi, Omar
    Harvey, Elizabeth
    Daniels, Kelly
    McGuirk, Joseph
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S178 - S178
  • [42] Peripheral blood stem cell mobilization with a single dose of PEG-filgrastim in patients with multiple myeloma previously treated with radiotherapy
    Anguita-Compagnon, Alfonso T.
    Dibarrart, Maria T.
    Paredes, Laura
    Araos, Daniel
    Vargas, Marcela
    Majlis, Alejandro
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2724 - 2727
  • [43] Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)
    Tekgunduz, Emre
    Demirkan, Fatih
    Vural, Filiz
    Goker, Hakan
    Ozdogu, Hakan
    Kiki, Ilhami
    Aydogdu, Ismet
    Kaynar, Leylagul
    Erkurt, Mehmet Ali
    Cagirgan, Seckin
    Besisik, Sevgi
    Dagdas, Simten
    Koca, Ebru
    Kadikoylu, Gurhan
    Gunduz, Eren
    Yilmaz, Mehmet
    Bekoz, Hulseyin
    Ural, Ali Ugur
    Basturk, Abdulkadir
    Arat, Mutlu
    Albayrak, Murat
    Ozturk, Erman
    Akyol, Alev
    Bolaman, Ali Zahit
    Nevruz, Oral
    Ozkan, Hasan Atilla
    Ozgur, Gokhan
    Altuntas, Fevzi
    TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (06) : 804 - 808
  • [44] DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients
    Zappasodi, Patrizia
    Nosari, Anna Maria
    Astori, Cesare
    Ciapanna, Dennis
    Bonfichi, Maurizio
    Varettoni, Marzia
    Mangiacavalli, Silvia
    Morra, Enrica
    Lazzarino, Mario
    Corso, Alessandro
    TRANSFUSION, 2008, 48 (05) : 857 - 860
  • [45] Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients with Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem Cell Transplantation
    Restelli, Umberto
    Croce, Davide
    Bonizzoni, Erminio
    Marzanatti, Mario
    Andreini, Angelo
    Sorio, Marco
    Tecchio, Cristina
    Barison, Erika
    Benedetti, Fabio
    JOURNAL OF BLOOD MEDICINE, 2020, 11 : 123 - 130
  • [46] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF LENOGRASTIM VS FILGRASTIM FOR MOBILIZATION OF PERIPHERAL BLOOD PROGENITOR CELLS IN PATIENTS WITH LYMPHOMA AND MYELOMA RECEIVING CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION
    Benedetti, F.
    Restelli, U.
    Croce, D.
    Bonizzoni, E.
    Marzanatti, M.
    Andreini, A.
    Sorio, M.
    Tecchio, C.
    Barison, E.
    Costantini, C.
    de Sabata, D.
    HAEMATOLOGICA, 2017, 102 : 149 - 150
  • [47] NIS OPTIMOB: First results of real-world data on mobilization and collection of hematopoietic stem and progenitor cells in patients with multiple myeloma and lymphoma in Germany
    Bittrich, M.
    Movassaghi, K.
    Vucinic, V.
    Grube, M.
    Kriegsmann, K.
    Duerk, H. A.
    Kunz, C.
    Wehler, D.
    Metzner, B.
    Hentrich, M.
    de Wit, M.
    Schmidt-Hieber, M.
    Humpe, A.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 242 - 243
  • [48] Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: An economic evaluation of the PALM trial
    Perrier L.
    Lefranc A.
    Pérol D.
    Quittet P.
    Schmidt-Tanguy A.
    Siani C.
    De Peretti C.
    Favier B.
    Biron P.
    Moreau P.
    Bay J.O.
    Lissandre S.
    Jardin F.
    Espinouse D.
    Sebban C.
    Applied Health Economics and Health Policy, 2013, 11 (2) : 129 - 138
  • [49] Kinetics of Myeloid-Derived Suppressor Cells during Stem Cell Mobilization and Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients
    Betsch, Anika
    Rutgeerts, Omer
    Fevery, Sabine
    Sprangers, Ben
    Dierickx, Daan
    Beckers, Marielle
    BLOOD, 2018, 132
  • [50] Hematopoietic progenitor cell mobilization and transplantation is feasible even after autologous SCT in heavily pre-treated patients with multiple myeloma
    Guenther, A.
    Schub, N.
    Buwitt-Beckmann, U.
    Trost, B.
    Humpe, A.
    Gramatzki, M.
    ONKOLOGIE, 2013, 36 : 237 - 237
12345